• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者的生活质量——与抑郁症状和身体残疾的关联:一项前瞻性观察研究。

The quality of life in patients with multiple sclerosis - Association with depressive symptoms and physical disability: A prospective and observational study.

作者信息

Kołtuniuk Aleksandra, Pawlak Beata, Krówczyńska Dorota, Chojdak-Łukasiewicz Justyna

机构信息

Division of Internal Medicine Nursing, Wroclaw Medical University, Wroclaw, Poland.

Cardinal Stefan Wyszynski Institute of Cardiology, Warsaw, Poland.

出版信息

Front Psychol. 2023 Jan 6;13:1068421. doi: 10.3389/fpsyg.2022.1068421. eCollection 2022.

DOI:10.3389/fpsyg.2022.1068421
PMID:36687950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9853525/
Abstract

BACKGROUND

Patients with multiple sclerosis (MS) experience disabilities which significantly affect their quality of life (QOL) and mental health. Mood disorders and depressive symptoms are one of the most common psychiatric conditions in MS patients. This study aimed to evaluate the level of QOL in MS patients and to assess the influence of depressive symptoms and physical disability on QOL.

METHODS

This prospective and observational study was conducted among 100 MS patients (mean age of 36.23 ± 11.77) recruited from the Lower Silesian Unit of the Polish Association for Multiple Sclerosis. This study used a questionnaire designed by the authors, which contained questions about sociodemographic and clinical data, as well as the following standardized questionnaires: the Activities of Daily Living questionnaire (ADL), the Instrumental Activities of Daily Living questionnaire (IADL), the Expanded Disability Status Scale (EDSS), the Beck Depression Inventory (BDI) and Multiple Sclerosis International Quality of Life Questionnaire (MusiQOL).

RESULTS

The average EDSS score among patients was 3.13 ± 2.38 points. More than half of the respondents (68%) suffered from depression of varying severity. The univariate linear regression models showed that the independent ( < 0.05) QOL predictors (total MusiQOL) were as follows: the number of complaints, IADL results, BDI results, EDSS score, higher education, and material status >2000 PLN. In addition, the multiple linear regression model showed that the BDI result was a significant predictor of QOL ( < 0.005).

CONCLUSION

Depressive symptoms significantly affect the QOL of MS patients.

摘要

背景

多发性硬化症(MS)患者存在残疾,这严重影响他们的生活质量(QOL)和心理健康。情绪障碍和抑郁症状是MS患者中最常见的精神疾病之一。本研究旨在评估MS患者的生活质量水平,并评估抑郁症状和身体残疾对生活质量的影响。

方法

这项前瞻性观察性研究在从波兰多发性硬化症协会下西里西亚分会招募的100名MS患者(平均年龄36.23±11.77岁)中进行。本研究使用了作者设计的问卷,其中包含有关社会人口统计学和临床数据的问题,以及以下标准化问卷:日常生活活动问卷(ADL)、工具性日常生活活动问卷(IADL)、扩展残疾状态量表(EDSS)、贝克抑郁量表(BDI)和多发性硬化症国际生活质量问卷(MusiQOL)。

结果

患者的平均EDSS评分为3.13±2.38分。超过一半的受访者(68%)患有不同严重程度的抑郁症。单变量线性回归模型显示,独立的(<0.05)生活质量预测因素(MusiQOL总分)如下:投诉次数、IADL结果、BDI结果、EDSS评分、高等教育程度和物质状况>2000波兰兹罗提。此外,多元线性回归模型显示,BDI结果是生活质量的显著预测因素(<0.005)。

结论

抑郁症状显著影响MS患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58a/9853525/71f08c3d755d/fpsyg-13-1068421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58a/9853525/368a56f2d6f2/fpsyg-13-1068421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58a/9853525/71f08c3d755d/fpsyg-13-1068421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58a/9853525/368a56f2d6f2/fpsyg-13-1068421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b58a/9853525/71f08c3d755d/fpsyg-13-1068421-g002.jpg

相似文献

1
The quality of life in patients with multiple sclerosis - Association with depressive symptoms and physical disability: A prospective and observational study.多发性硬化症患者的生活质量——与抑郁症状和身体残疾的关联:一项前瞻性观察研究。
Front Psychol. 2023 Jan 6;13:1068421. doi: 10.3389/fpsyg.2022.1068421. eCollection 2022.
2
Exploring the relationship between disability status, depression, and quality of life in individuals with multiple sclerosis.探讨多发性硬化症患者残疾状况、抑郁和生活质量之间的关系。
Mult Scler Relat Disord. 2024 Jul;87:105629. doi: 10.1016/j.msard.2024.105629. Epub 2024 May 10.
3
Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study.抑郁、疲劳和残疾与多发性硬化症患者的生活质量独立相关:一项横断面研究的结果。
Mult Scler Relat Disord. 2019 Oct;35:262-269. doi: 10.1016/j.msard.2019.07.029. Epub 2019 Jul 28.
4
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).那他珠单抗治疗多发性硬化症患者的残疾与生活质量的相关性:TYSabri改善研究(PROTYS)的主要结果及事后分析
BMJ Neurol Open. 2023 Jan 26;5(1):e000304. doi: 10.1136/bmjno-2022-000304. eCollection 2023.
5
Quality of life and social support in patients with multiple sclerosis.多发性硬化症患者的生活质量和社会支持。
Neurol Neurochir Pol. 2010 Jul-Aug;44(4):358-65. doi: 10.1016/s0028-3843(14)60295-4.
6
Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study.在大流行时代多发性硬化症患者中的抑郁、焦虑和对 COVID-19 的恐惧:一项横断面研究。
Neurol Sci. 2022 Jan;43(1):59-66. doi: 10.1007/s10072-021-05612-5. Epub 2021 Sep 23.
7
Sleep Disturbances, Degree of Disability and the Quality of Life in Multiple Sclerosis Patients.多发性硬化症患者的睡眠障碍、残疾程度与生活质量
Int J Environ Res Public Health. 2022 Mar 10;19(6):3271. doi: 10.3390/ijerph19063271.
8
Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.患有多发性硬化症的国际患者群体的特征及其生活质量的决定因素:使用 MusiQoL 和 SF-36 问卷进行评估。
Mult Scler. 2011 Oct;17(10):1238-49. doi: 10.1177/1352458511407951. Epub 2011 Jun 13.
9
Validation of Italian multiple sclerosis quality of life 54 questionnaire.意大利多发性硬化症生活质量54问卷的验证
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62. doi: 10.1136/jnnp.67.2.158.
10
Health-related quality of life in Japanese patients with multiple sclerosis.日本多发性硬化症患者的健康相关生活质量
J Neurol. 2023 Feb;270(2):1011-1018. doi: 10.1007/s00415-022-11453-9. Epub 2022 Nov 5.

引用本文的文献

1
From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.从分子到模型:微小RNA与多发性硬化症神经退行性变和修复的先进人类平台
Int J Mol Sci. 2025 Sep 8;26(17):8740. doi: 10.3390/ijms26178740.
2
Impact of Depression, Fatigue, and Pain on Quality of Life in Slovak Multiple Sclerosis Patients.抑郁症、疲劳和疼痛对斯洛伐克多发性硬化症患者生活质量的影响。
Med Sci Monit. 2025 Apr 26;31:e947630. doi: 10.12659/MSM.947630.
3
Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experience.

本文引用的文献

1
Identification of cognitive impairment, depression, and fatigue among multiple sclerosis patients in a large comprehensive care center: A mixed-methods, qualitative study.大型综合护理中心多发性硬化症患者认知障碍、抑郁和疲劳的识别:一项混合方法的定性研究。
Mult Scler Relat Disord. 2022 Dec;68:104117. doi: 10.1016/j.msard.2022.104117. Epub 2022 Aug 20.
2
Health-related Quality of Life of People with Multiple Sclerosis in Oman.阿曼多发性硬化症患者的健康相关生活质量
Oman Med J. 2021 Nov 15;36(6):e318. doi: 10.5001/omj.2021.109. eCollection 2021 Nov.
3
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
经济危机期间多发性硬化症患者的生活质量与治疗可及性:黎巴嫩的经验
Qual Life Res. 2025 Apr 15. doi: 10.1007/s11136-025-03970-7.
4
Sociodemographic and Clinical Determinants of the Quality of Life of Moroccan People With Multiple Sclerosis.摩洛哥多发性硬化症患者生活质量的社会人口学和临床决定因素
Int J MS Care. 2025 Jan 27;27(Q1):25-33. doi: 10.7224/1537-2073.2024-036. eCollection 2025 Jan.
5
The Potential of Transcranial Direct Current Stimulation (tDCS) in Improving Quality of Life in Patients with Multiple Sclerosis: A Review and Discussion of Mechanisms of Action.经颅直流电刺激(tDCS)改善多发性硬化症患者生活质量的潜力:作用机制的综述与探讨
J Clin Med. 2025 Jan 9;14(2):373. doi: 10.3390/jcm14020373.
6
A positive psychotherapy group intervention to increase distress tolerance and reduce feelings of entrapment in patients with multiple sclerosis.一项积极心理治疗团体干预措施,旨在提高多发性硬化症患者的痛苦耐受力并减少被困感。
J Educ Health Promot. 2024 Nov 29;13:418. doi: 10.4103/jehp.jehp_2093_23. eCollection 2024.
7
Biopsychosocial Impact of Multiple Sclerosis in Omani Patients: A Multicenter Comparative Study.阿曼患者多发性硬化症的生物心理社会影响:一项多中心对比研究。
J Clin Med. 2024 Oct 22;13(21):6315. doi: 10.3390/jcm13216315.
8
Clinical characteristics and impairment of activities of daily living among patients with myasthenia gravis with differing degrees of muscle weakness: a real-world study of patients in the US and five European countries.在患有不同程度肌无力的重症肌无力患者中,临床特征和日常生活活动能力受损的情况:来自美国和五个欧洲国家的真实世界研究。
BMC Neurol. 2024 Oct 12;24(1):385. doi: 10.1186/s12883-024-03869-9.
9
The Effectiveness of Vitamin D Intake in Improving Symptoms and Relapses of Multiple Sclerosis: A Systematic Review.维生素D摄入对改善多发性硬化症状及复发的有效性:一项系统评价
Cureus. 2024 Sep 3;16(9):e68565. doi: 10.7759/cureus.68565. eCollection 2024 Sep.
10
Depressive Symptoms in Multiple Sclerosis: Links to Body Composition, Physical Activity, and Functional Ability.多发性硬化症中的抑郁症状:与身体成分、身体活动和功能能力的关系。
Med Sci Monit. 2024 Oct 4;30:e943977. doi: 10.12659/MSM.943977.
2020 年 COVID-19 大流行期间 204 个国家和地区的抑郁和焦虑障碍的全球患病率和负担。
Lancet. 2021 Nov 6;398(10312):1700-1712. doi: 10.1016/S0140-6736(21)02143-7. Epub 2021 Oct 8.
4
A Prospective Multicenter Study for Assessing MusiQoL Validity among Arabic-Speaking MS Patients Treated with Subcutaneous Interferon -1a.一项评估皮下注射干扰素-1a治疗的阿拉伯语多发性硬化症患者中MusiQoL有效性的前瞻性多中心研究。
Mult Scler Int. 2021 Mar 2;2021:6681431. doi: 10.1155/2021/6681431. eCollection 2021.
5
A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study.一项前瞻性、观察性、队列研究,评估延长释放型芬戈莫德在多发性硬化症患者认知、疲劳、抑郁和生活质量方面的疗效和安全性:FAMILY 研究。
Adv Ther. 2021 Mar;38(3):1536-1551. doi: 10.1007/s12325-020-01606-5. Epub 2021 Feb 2.
6
The Levels of Depression, Anxiety, Acceptance of Illness, and Medication Adherence in Patients with Multiple Sclerosis - Descriptive and Correlational Study.多发性硬化症患者的抑郁、焦虑、疾病接受度和药物依从性水平 - 描述性和相关性研究。
Int J Med Sci. 2021 Jan 1;18(1):216-225. doi: 10.7150/ijms.51172. eCollection 2021.
7
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.全球多发性硬化症患病率上升:第三版多发性硬化症图谱的见解。
Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11.
8
Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life.多发性硬化症(MS)中的焦虑和抑郁:先兆、后果以及对幸福感和生活质量的不同影响。
Mult Scler Relat Disord. 2020 Sep;44:102261. doi: 10.1016/j.msard.2020.102261. Epub 2020 Jun 6.
9
Factors affecting MS patients' health-related quality of life and measurement challenges in Lebanon and the MENA region.影响黎巴嫩及中东和北非地区多发性硬化症患者健康相关生活质量的因素及测量挑战。
Mult Scler J Exp Transl Clin. 2020 Jan 9;6(1):2055217319848467. doi: 10.1177/2055217319848467. eCollection 2020 Jan-Mar.
10
Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability.多发性硬化症患者的生活质量及其与抑郁症状和身体残疾的关系。
Mult Scler Relat Disord. 2019 Nov;36:101386. doi: 10.1016/j.msard.2019.101386. Epub 2019 Sep 9.